MSA Advisors’s Novo Nordisk NVO Stock Holding History

MSA Advisors’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,500	Closed	-$129K	–	49
2026 Q1	$129K	Hold	3,500	–	–	0.04%	47
2025 Q4	$178K	Hold	3,500	–	–	0.04%	27
2025 Q3	$194K	Hold	3,500	–	–	0.05%	27
2025 Q2	$242K	Hold	3,500	–	–	0.06%	24
2025 Q1	$243K	Hold	3,500	–	–	0.06%	26
2024 Q4	$301K	Hold	3,500	–	–	0.08%	23
2024 Q3	$417K	Hold	3,500	–	–	0.11%	21
2024 Q2	$500K	Hold	3,500	–	–	0.14%	20
2024 Q1	$452K	Hold	3,500	–	–	0.14%	20
2023 Q4	$362K	Buy	+3,500	New	+$346K	0.13%	19

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

MSA Advisors's NVO Position: Q2 2026 in Review

MSA Advisors sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 3,500 shares — an estimated $129K sold.

MSA Advisors first reported a position in NVO in Q4 2023 and held it in 10 quarters. The position peaked at $500K in Q2 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

MSA Advisors reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
MSA Advisors sold 3,500 Novo Nordisk shares in Q2 2026, an estimated $129K.
MSA Advisors first reported a position in Novo Nordisk in Q4 2023 and held it in 10 quarters.
MSA Advisors's Novo Nordisk position peaked at $500K in Q2 2024.
1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on MSA Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.